Collectively, the above results indicate that FN-EDA stimulates the expression of SHMT1 and FN-EDA/NF-κB/SHMT1pathway is closely associated with the sorafenib-resistant capacity of HCC cells. Here, FN1 is linked to hepatocellular carcinoma.